RecruitingPhase 3NCT06282315
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
Studying Ankylostomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Insud Pharma
- Principal Investigator
- Alejandro Krolewiecki, MD, LMFTInsud Pharma
- Intervention
- Pre-screening Phase(drug)
- Enrollment
- 20000 enrolled
- Eligibility
- 5-17 years · All sexes
- Timeline
- 2025 – 2027
Study locations (2)
- Ghana Health Service (GHS), Accra, Accra, Ghana
- Kenya Medical Research Institution (KEMRI), Nairobi, Nairobi County, Kenya
Collaborators
Ghana Health Services · Kenya Medical Research Institute · Bridges to Development · Sanger Institute · Barcelona Institute for Global Health · European Union · Swiss Confederation · Fundación Mundo Sano
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06282315 on ClinicalTrials.govOther trials for Ankylostomiasis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT06736691Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth InfectionsSwiss Tropical & Public Health Institute
- RECRUITINGPHASE4NCT07145736Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical DiseasesKirby Institute
- RECRUITINGPHASE3NCT06128447Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)Zero Point Five Therapeutics
- RECRUITINGPHASE1NCT01940757Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm LarvaeBaylor College of Medicine